Skip to main content

Table 4 Comparison of medical resource use in the 3 months before and after repository corticotropin injection treatment

From: A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States

Resource useConditiona Mean number per patientMean differenceSD95% CI
LowerUpper
Pre-RCIPost- RCI
Hospital admissions (count)RA0.070.02− 0.053*0.373− 0.103− 0.003
PsA0.240.16− 0.079*0.334− 0.127− 0.031
DM/PM0.460.19− 0.271*0.672− 0.356− 0.187
SLE0.170.03− 0.137*0.426− 0.224− 0.05
Hospital days (days)RA0.230.04− 0.191*1.405− 0.379− 0.003
PsA0.370.15− 0.222*0.984− 0.363− 0.08
DM/PM1.420.35− 1.064*3.181− 1.465− 0.664
SLE0.450.04− 0.41*1.64− 0.745− 0.075
Outpatient visits (count)RA2.802.38− 0.426*1.306− 0.6− 0.251
PsA3.182.46− 0.72*1.46− 0.93− 0.51
DM/PM2.722.01− 0.71*1.791− 0.936− 0.485
SLE2.742.55− 0.1881.843− 0.5640.188
  1. CI confidence interval, DM/PM dermatomyositis/polymyositis, PsA psoriatic arthritis, RA rheumatoid arthritis, RCI repository corticotropin injection, SD standard deviation, SLE systemic lupus erythematosus
  2. * P < 0.05
  3. aRA, n = 217; PsA, n = 188; DM/PM, n = 245; SLE, n = 95 (number of patients differs from overall counts because of missing data for 2 PsA and 9 DM/PM patients)